nodes	percent_of_prediction	percent_of_DWPC	metapath
Darifenacin—CYP2D6—Vinorelbine—ovarian cancer	0.0842	0.255	CbGbCtD
Darifenacin—CYP3A4—Topotecan—ovarian cancer	0.076	0.23	CbGbCtD
Darifenacin—CYP3A4—Vinorelbine—ovarian cancer	0.0535	0.162	CbGbCtD
Darifenacin—CYP3A4—Paclitaxel—ovarian cancer	0.0376	0.114	CbGbCtD
Darifenacin—CYP2D6—Doxorubicin—ovarian cancer	0.0319	0.0964	CbGbCtD
Darifenacin—CYP3A4—Docetaxel—ovarian cancer	0.0272	0.0822	CbGbCtD
Darifenacin—CYP3A4—Doxorubicin—ovarian cancer	0.0203	0.0613	CbGbCtD
Darifenacin—Diarrhoea—Topotecan—ovarian cancer	0.00151	0.00225	CcSEcCtD
Darifenacin—Cerebrovascular accident—Epirubicin—ovarian cancer	0.0015	0.00225	CcSEcCtD
Darifenacin—Back pain—Paclitaxel—ovarian cancer	0.0015	0.00225	CcSEcCtD
Darifenacin—Pharyngitis—Docetaxel—ovarian cancer	0.0015	0.00224	CcSEcCtD
Darifenacin—Urinary tract disorder—Docetaxel—ovarian cancer	0.00149	0.00223	CcSEcCtD
Darifenacin—Abdominal pain—Vinorelbine—ovarian cancer	0.00149	0.00223	CcSEcCtD
Darifenacin—Oedema peripheral—Docetaxel—ovarian cancer	0.00149	0.00223	CcSEcCtD
Darifenacin—Urethral disorder—Docetaxel—ovarian cancer	0.00148	0.00222	CcSEcCtD
Darifenacin—Diarrhoea—Melphalan—ovarian cancer	0.00147	0.00221	CcSEcCtD
Darifenacin—Nausea—Chlorambucil—ovarian cancer	0.00147	0.0022	CcSEcCtD
Darifenacin—Vision blurred—Paclitaxel—ovarian cancer	0.00146	0.00219	CcSEcCtD
Darifenacin—Visual impairment—Docetaxel—ovarian cancer	0.00146	0.00218	CcSEcCtD
Darifenacin—Dizziness—Topotecan—ovarian cancer	0.00146	0.00218	CcSEcCtD
Darifenacin—Erythema multiforme—Docetaxel—ovarian cancer	0.00143	0.00214	CcSEcCtD
Darifenacin—Face oedema—Epirubicin—ovarian cancer	0.00142	0.00213	CcSEcCtD
Darifenacin—Angioedema—Paclitaxel—ovarian cancer	0.00142	0.00212	CcSEcCtD
Darifenacin—Eye disorder—Docetaxel—ovarian cancer	0.00141	0.00211	CcSEcCtD
Darifenacin—Vomiting—Topotecan—ovarian cancer	0.0014	0.0021	CcSEcCtD
Darifenacin—Syncope—Paclitaxel—ovarian cancer	0.00139	0.00208	CcSEcCtD
Darifenacin—Cerebrovascular accident—Doxorubicin—ovarian cancer	0.00139	0.00208	CcSEcCtD
Darifenacin—Rash—Topotecan—ovarian cancer	0.00139	0.00208	CcSEcCtD
Darifenacin—Hypersensitivity—Vinorelbine—ovarian cancer	0.00139	0.00208	CcSEcCtD
Darifenacin—Dermatitis—Topotecan—ovarian cancer	0.00139	0.00208	CcSEcCtD
Darifenacin—Headache—Topotecan—ovarian cancer	0.00138	0.00206	CcSEcCtD
Darifenacin—Palpitations—Paclitaxel—ovarian cancer	0.00137	0.00205	CcSEcCtD
Darifenacin—Angiopathy—Docetaxel—ovarian cancer	0.00137	0.00205	CcSEcCtD
Darifenacin—Vomiting—Melphalan—ovarian cancer	0.00137	0.00205	CcSEcCtD
Darifenacin—Loss of consciousness—Paclitaxel—ovarian cancer	0.00136	0.00204	CcSEcCtD
Darifenacin—Mediastinal disorder—Docetaxel—ovarian cancer	0.00136	0.00204	CcSEcCtD
Darifenacin—Rash—Melphalan—ovarian cancer	0.00136	0.00203	CcSEcCtD
Darifenacin—Dermatitis—Melphalan—ovarian cancer	0.00136	0.00203	CcSEcCtD
Darifenacin—Cough—Paclitaxel—ovarian cancer	0.00135	0.00203	CcSEcCtD
Darifenacin—Asthenia—Vinorelbine—ovarian cancer	0.00135	0.00202	CcSEcCtD
Darifenacin—Dry skin—Epirubicin—ovarian cancer	0.00135	0.00202	CcSEcCtD
Darifenacin—Hypertension—Paclitaxel—ovarian cancer	0.00134	0.00201	CcSEcCtD
Darifenacin—Pruritus—Vinorelbine—ovarian cancer	0.00133	0.00199	CcSEcCtD
Darifenacin—Breast disorder—Epirubicin—ovarian cancer	0.00133	0.00199	CcSEcCtD
Darifenacin—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	0.00133	0.00199	CcSEcCtD
Darifenacin—Mental disorder—Docetaxel—ovarian cancer	0.00132	0.00198	CcSEcCtD
Darifenacin—Arthralgia—Paclitaxel—ovarian cancer	0.00132	0.00198	CcSEcCtD
Darifenacin—Face oedema—Doxorubicin—ovarian cancer	0.00132	0.00197	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00131	0.00196	CcSEcCtD
Darifenacin—Nausea—Topotecan—ovarian cancer	0.00131	0.00196	CcSEcCtD
Darifenacin—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.0013	0.00195	CcSEcCtD
Darifenacin—Dry mouth—Paclitaxel—ovarian cancer	0.00129	0.00193	CcSEcCtD
Darifenacin—Diarrhoea—Vinorelbine—ovarian cancer	0.00129	0.00193	CcSEcCtD
Darifenacin—Dysgeusia—Docetaxel—ovarian cancer	0.00129	0.00193	CcSEcCtD
Darifenacin—Nausea—Melphalan—ovarian cancer	0.00128	0.00192	CcSEcCtD
Darifenacin—Confusional state—Paclitaxel—ovarian cancer	0.00128	0.00191	CcSEcCtD
Darifenacin—Influenza—Epirubicin—ovarian cancer	0.00127	0.00191	CcSEcCtD
Darifenacin—Back pain—Docetaxel—ovarian cancer	0.00127	0.0019	CcSEcCtD
Darifenacin—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00127	0.0019	CcSEcCtD
Darifenacin—Oedema—Paclitaxel—ovarian cancer	0.00127	0.0019	CcSEcCtD
Darifenacin—Infection—Paclitaxel—ovarian cancer	0.00126	0.00188	CcSEcCtD
Darifenacin—Dry skin—Doxorubicin—ovarian cancer	0.00125	0.00187	CcSEcCtD
Darifenacin—Shock—Paclitaxel—ovarian cancer	0.00125	0.00187	CcSEcCtD
Darifenacin—Dizziness—Vinorelbine—ovarian cancer	0.00125	0.00186	CcSEcCtD
Darifenacin—Nervous system disorder—Paclitaxel—ovarian cancer	0.00124	0.00186	CcSEcCtD
Darifenacin—Tachycardia—Paclitaxel—ovarian cancer	0.00124	0.00185	CcSEcCtD
Darifenacin—Breast disorder—Doxorubicin—ovarian cancer	0.00123	0.00184	CcSEcCtD
Darifenacin—Skin disorder—Paclitaxel—ovarian cancer	0.00123	0.00184	CcSEcCtD
Darifenacin—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.00123	0.00184	CcSEcCtD
Darifenacin—Bronchitis—Epirubicin—ovarian cancer	0.00122	0.00183	CcSEcCtD
Darifenacin—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00122	0.00183	CcSEcCtD
Darifenacin—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.0012	0.0018	CcSEcCtD
Darifenacin—Vomiting—Vinorelbine—ovarian cancer	0.0012	0.00179	CcSEcCtD
Darifenacin—Rash—Vinorelbine—ovarian cancer	0.00119	0.00178	CcSEcCtD
Darifenacin—Dermatitis—Vinorelbine—ovarian cancer	0.00119	0.00178	CcSEcCtD
Darifenacin—Headache—Vinorelbine—ovarian cancer	0.00118	0.00177	CcSEcCtD
Darifenacin—Syncope—Docetaxel—ovarian cancer	0.00118	0.00177	CcSEcCtD
Darifenacin—Influenza—Doxorubicin—ovarian cancer	0.00118	0.00176	CcSEcCtD
Darifenacin—Palpitations—Docetaxel—ovarian cancer	0.00116	0.00174	CcSEcCtD
Darifenacin—Weight increased—Epirubicin—ovarian cancer	0.00116	0.00173	CcSEcCtD
Darifenacin—Loss of consciousness—Docetaxel—ovarian cancer	0.00116	0.00173	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00115	0.00173	CcSEcCtD
Darifenacin—Cough—Docetaxel—ovarian cancer	0.00115	0.00172	CcSEcCtD
Darifenacin—Insomnia—Paclitaxel—ovarian cancer	0.00115	0.00171	CcSEcCtD
Darifenacin—Hypertension—Docetaxel—ovarian cancer	0.00114	0.0017	CcSEcCtD
Darifenacin—Infestation NOS—Epirubicin—ovarian cancer	0.00114	0.0017	CcSEcCtD
Darifenacin—Infestation—Epirubicin—ovarian cancer	0.00114	0.0017	CcSEcCtD
Darifenacin—Bronchitis—Doxorubicin—ovarian cancer	0.00113	0.0017	CcSEcCtD
Darifenacin—Dyspnoea—Paclitaxel—ovarian cancer	0.00113	0.00169	CcSEcCtD
Darifenacin—Somnolence—Paclitaxel—ovarian cancer	0.00113	0.00169	CcSEcCtD
Darifenacin—Arthralgia—Docetaxel—ovarian cancer	0.00112	0.00168	CcSEcCtD
Darifenacin—Nausea—Vinorelbine—ovarian cancer	0.00112	0.00167	CcSEcCtD
Darifenacin—Dyspepsia—Paclitaxel—ovarian cancer	0.00111	0.00167	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00111	0.00166	CcSEcCtD
Darifenacin—Stomatitis—Epirubicin—ovarian cancer	0.00111	0.00166	CcSEcCtD
Darifenacin—Urinary tract infection—Epirubicin—ovarian cancer	0.0011	0.00165	CcSEcCtD
Darifenacin—Dry mouth—Docetaxel—ovarian cancer	0.0011	0.00164	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00109	0.00164	CcSEcCtD
Darifenacin—Sweating—Epirubicin—ovarian cancer	0.00109	0.00163	CcSEcCtD
Darifenacin—Pain—Paclitaxel—ovarian cancer	0.00108	0.00162	CcSEcCtD
Darifenacin—Constipation—Paclitaxel—ovarian cancer	0.00108	0.00162	CcSEcCtD
Darifenacin—Confusional state—Docetaxel—ovarian cancer	0.00108	0.00162	CcSEcCtD
Darifenacin—Anaphylactic shock—Docetaxel—ovarian cancer	0.00107	0.00161	CcSEcCtD
Darifenacin—Oedema—Docetaxel—ovarian cancer	0.00107	0.00161	CcSEcCtD
Darifenacin—Weight increased—Doxorubicin—ovarian cancer	0.00107	0.00161	CcSEcCtD
Darifenacin—Infection—Docetaxel—ovarian cancer	0.00107	0.0016	CcSEcCtD
Darifenacin—Sinusitis—Epirubicin—ovarian cancer	0.00107	0.00159	CcSEcCtD
Darifenacin—Shock—Docetaxel—ovarian cancer	0.00106	0.00158	CcSEcCtD
Darifenacin—Nervous system disorder—Docetaxel—ovarian cancer	0.00105	0.00158	CcSEcCtD
Darifenacin—Infestation—Doxorubicin—ovarian cancer	0.00105	0.00157	CcSEcCtD
Darifenacin—Infestation NOS—Doxorubicin—ovarian cancer	0.00105	0.00157	CcSEcCtD
Darifenacin—Tachycardia—Docetaxel—ovarian cancer	0.00105	0.00157	CcSEcCtD
Darifenacin—Feeling abnormal—Paclitaxel—ovarian cancer	0.00104	0.00156	CcSEcCtD
Darifenacin—Skin disorder—Docetaxel—ovarian cancer	0.00104	0.00156	CcSEcCtD
Darifenacin—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00104	0.00155	CcSEcCtD
Darifenacin—Stomatitis—Doxorubicin—ovarian cancer	0.00102	0.00153	CcSEcCtD
Darifenacin—Rhinitis—Epirubicin—ovarian cancer	0.00102	0.00153	CcSEcCtD
Darifenacin—Urinary tract infection—Doxorubicin—ovarian cancer	0.00102	0.00153	CcSEcCtD
Darifenacin—Pharyngitis—Epirubicin—ovarian cancer	0.00101	0.00151	CcSEcCtD
Darifenacin—Sweating—Doxorubicin—ovarian cancer	0.00101	0.00151	CcSEcCtD
Darifenacin—Urinary tract disorder—Epirubicin—ovarian cancer	0.00101	0.00151	CcSEcCtD
Darifenacin—Oedema peripheral—Epirubicin—ovarian cancer	0.001	0.0015	CcSEcCtD
Darifenacin—Abdominal pain—Paclitaxel—ovarian cancer	0.001	0.0015	CcSEcCtD
Darifenacin—Urethral disorder—Epirubicin—ovarian cancer	0.000999	0.0015	CcSEcCtD
Darifenacin—Sinusitis—Doxorubicin—ovarian cancer	0.000985	0.00148	CcSEcCtD
Darifenacin—Visual impairment—Epirubicin—ovarian cancer	0.000982	0.00147	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000978	0.00146	CcSEcCtD
Darifenacin—Insomnia—Docetaxel—ovarian cancer	0.000971	0.00145	CcSEcCtD
Darifenacin—Erythema multiforme—Epirubicin—ovarian cancer	0.000964	0.00144	CcSEcCtD
Darifenacin—Dyspnoea—Docetaxel—ovarian cancer	0.000957	0.00143	CcSEcCtD
Darifenacin—Somnolence—Docetaxel—ovarian cancer	0.000954	0.00143	CcSEcCtD
Darifenacin—Eye disorder—Epirubicin—ovarian cancer	0.000952	0.00143	CcSEcCtD
Darifenacin—Rhinitis—Doxorubicin—ovarian cancer	0.000945	0.00142	CcSEcCtD
Darifenacin—Dyspepsia—Docetaxel—ovarian cancer	0.000945	0.00141	CcSEcCtD
Darifenacin—Pharyngitis—Doxorubicin—ovarian cancer	0.000936	0.0014	CcSEcCtD
Darifenacin—Hypersensitivity—Paclitaxel—ovarian cancer	0.000933	0.0014	CcSEcCtD
Darifenacin—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000931	0.00139	CcSEcCtD
Darifenacin—Oedema peripheral—Doxorubicin—ovarian cancer	0.000929	0.00139	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000927	0.00139	CcSEcCtD
Darifenacin—Angiopathy—Epirubicin—ovarian cancer	0.000925	0.00138	CcSEcCtD
Darifenacin—Urethral disorder—Doxorubicin—ovarian cancer	0.000924	0.00138	CcSEcCtD
Darifenacin—Mediastinal disorder—Epirubicin—ovarian cancer	0.000918	0.00137	CcSEcCtD
Darifenacin—Pain—Docetaxel—ovarian cancer	0.000918	0.00137	CcSEcCtD
Darifenacin—Constipation—Docetaxel—ovarian cancer	0.000918	0.00137	CcSEcCtD
Darifenacin—Visual impairment—Doxorubicin—ovarian cancer	0.000909	0.00136	CcSEcCtD
Darifenacin—Asthenia—Paclitaxel—ovarian cancer	0.000909	0.00136	CcSEcCtD
Darifenacin—Pruritus—Paclitaxel—ovarian cancer	0.000896	0.00134	CcSEcCtD
Darifenacin—Mental disorder—Epirubicin—ovarian cancer	0.000893	0.00134	CcSEcCtD
Darifenacin—Erythema multiforme—Doxorubicin—ovarian cancer	0.000892	0.00133	CcSEcCtD
Darifenacin—Feeling abnormal—Docetaxel—ovarian cancer	0.000885	0.00132	CcSEcCtD
Darifenacin—Eye disorder—Doxorubicin—ovarian cancer	0.000881	0.00132	CcSEcCtD
Darifenacin—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000878	0.00131	CcSEcCtD
Darifenacin—Flatulence—Epirubicin—ovarian cancer	0.000874	0.00131	CcSEcCtD
Darifenacin—Dysgeusia—Epirubicin—ovarian cancer	0.000869	0.0013	CcSEcCtD
Darifenacin—Diarrhoea—Paclitaxel—ovarian cancer	0.000866	0.0013	CcSEcCtD
Darifenacin—Back pain—Epirubicin—ovarian cancer	0.000858	0.00128	CcSEcCtD
Darifenacin—Angiopathy—Doxorubicin—ovarian cancer	0.000856	0.00128	CcSEcCtD
Darifenacin—Mediastinal disorder—Doxorubicin—ovarian cancer	0.00085	0.00127	CcSEcCtD
Darifenacin—Abdominal pain—Docetaxel—ovarian cancer	0.000849	0.00127	CcSEcCtD
Darifenacin—Dizziness—Paclitaxel—ovarian cancer	0.000837	0.00125	CcSEcCtD
Darifenacin—Vision blurred—Epirubicin—ovarian cancer	0.000836	0.00125	CcSEcCtD
Darifenacin—Mental disorder—Doxorubicin—ovarian cancer	0.000826	0.00124	CcSEcCtD
Darifenacin—Flatulence—Doxorubicin—ovarian cancer	0.000809	0.00121	CcSEcCtD
Darifenacin—Vomiting—Paclitaxel—ovarian cancer	0.000805	0.00121	CcSEcCtD
Darifenacin—Dysgeusia—Doxorubicin—ovarian cancer	0.000804	0.0012	CcSEcCtD
Darifenacin—Rash—Paclitaxel—ovarian cancer	0.000798	0.0012	CcSEcCtD
Darifenacin—Dermatitis—Paclitaxel—ovarian cancer	0.000798	0.00119	CcSEcCtD
Darifenacin—Syncope—Epirubicin—ovarian cancer	0.000796	0.00119	CcSEcCtD
Darifenacin—Back pain—Doxorubicin—ovarian cancer	0.000794	0.00119	CcSEcCtD
Darifenacin—Headache—Paclitaxel—ovarian cancer	0.000793	0.00119	CcSEcCtD
Darifenacin—Hypersensitivity—Docetaxel—ovarian cancer	0.000791	0.00118	CcSEcCtD
Darifenacin—Palpitations—Epirubicin—ovarian cancer	0.000784	0.00117	CcSEcCtD
Darifenacin—Loss of consciousness—Epirubicin—ovarian cancer	0.00078	0.00117	CcSEcCtD
Darifenacin—Cough—Epirubicin—ovarian cancer	0.000774	0.00116	CcSEcCtD
Darifenacin—Vision blurred—Doxorubicin—ovarian cancer	0.000774	0.00116	CcSEcCtD
Darifenacin—Asthenia—Docetaxel—ovarian cancer	0.00077	0.00115	CcSEcCtD
Darifenacin—Hypertension—Epirubicin—ovarian cancer	0.000766	0.00115	CcSEcCtD
Darifenacin—Pruritus—Docetaxel—ovarian cancer	0.000759	0.00114	CcSEcCtD
Darifenacin—Arthralgia—Epirubicin—ovarian cancer	0.000755	0.00113	CcSEcCtD
Darifenacin—Nausea—Paclitaxel—ovarian cancer	0.000752	0.00113	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.00075	0.00112	CcSEcCtD
Darifenacin—Dry mouth—Epirubicin—ovarian cancer	0.000739	0.00111	CcSEcCtD
Darifenacin—Syncope—Doxorubicin—ovarian cancer	0.000736	0.0011	CcSEcCtD
Darifenacin—Diarrhoea—Docetaxel—ovarian cancer	0.000734	0.0011	CcSEcCtD
Darifenacin—Confusional state—Epirubicin—ovarian cancer	0.00073	0.00109	CcSEcCtD
Darifenacin—Palpitations—Doxorubicin—ovarian cancer	0.000725	0.00109	CcSEcCtD
Darifenacin—Anaphylactic shock—Epirubicin—ovarian cancer	0.000724	0.00108	CcSEcCtD
Darifenacin—Oedema—Epirubicin—ovarian cancer	0.000724	0.00108	CcSEcCtD
Darifenacin—Loss of consciousness—Doxorubicin—ovarian cancer	0.000721	0.00108	CcSEcCtD
Darifenacin—Infection—Epirubicin—ovarian cancer	0.000719	0.00108	CcSEcCtD
Darifenacin—Cough—Doxorubicin—ovarian cancer	0.000716	0.00107	CcSEcCtD
Darifenacin—Shock—Epirubicin—ovarian cancer	0.000712	0.00107	CcSEcCtD
Darifenacin—Nervous system disorder—Epirubicin—ovarian cancer	0.00071	0.00106	CcSEcCtD
Darifenacin—Dizziness—Docetaxel—ovarian cancer	0.00071	0.00106	CcSEcCtD
Darifenacin—Hypertension—Doxorubicin—ovarian cancer	0.000709	0.00106	CcSEcCtD
Darifenacin—Tachycardia—Epirubicin—ovarian cancer	0.000707	0.00106	CcSEcCtD
Darifenacin—Skin disorder—Epirubicin—ovarian cancer	0.000703	0.00105	CcSEcCtD
Darifenacin—Hyperhidrosis—Epirubicin—ovarian cancer	0.0007	0.00105	CcSEcCtD
Darifenacin—Arthralgia—Doxorubicin—ovarian cancer	0.000699	0.00105	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000694	0.00104	CcSEcCtD
Darifenacin—Dry mouth—Doxorubicin—ovarian cancer	0.000683	0.00102	CcSEcCtD
Darifenacin—Vomiting—Docetaxel—ovarian cancer	0.000682	0.00102	CcSEcCtD
Darifenacin—Rash—Docetaxel—ovarian cancer	0.000677	0.00101	CcSEcCtD
Darifenacin—Dermatitis—Docetaxel—ovarian cancer	0.000676	0.00101	CcSEcCtD
Darifenacin—Confusional state—Doxorubicin—ovarian cancer	0.000675	0.00101	CcSEcCtD
Darifenacin—Headache—Docetaxel—ovarian cancer	0.000672	0.00101	CcSEcCtD
Darifenacin—Anaphylactic shock—Doxorubicin—ovarian cancer	0.00067	0.001	CcSEcCtD
Darifenacin—Oedema—Doxorubicin—ovarian cancer	0.00067	0.001	CcSEcCtD
Darifenacin—Infection—Doxorubicin—ovarian cancer	0.000666	0.000996	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.00066	0.000988	CcSEcCtD
Darifenacin—Shock—Doxorubicin—ovarian cancer	0.000659	0.000987	CcSEcCtD
Darifenacin—Nervous system disorder—Doxorubicin—ovarian cancer	0.000657	0.000984	CcSEcCtD
Darifenacin—Insomnia—Epirubicin—ovarian cancer	0.000655	0.00098	CcSEcCtD
Darifenacin—Tachycardia—Doxorubicin—ovarian cancer	0.000654	0.000979	CcSEcCtD
Darifenacin—Skin disorder—Doxorubicin—ovarian cancer	0.000651	0.000974	CcSEcCtD
Darifenacin—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000648	0.00097	CcSEcCtD
Darifenacin—Dyspnoea—Epirubicin—ovarian cancer	0.000645	0.000966	CcSEcCtD
Darifenacin—Somnolence—Epirubicin—ovarian cancer	0.000644	0.000964	CcSEcCtD
Darifenacin—Nausea—Docetaxel—ovarian cancer	0.000638	0.000955	CcSEcCtD
Darifenacin—Dyspepsia—Epirubicin—ovarian cancer	0.000637	0.000954	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000625	0.000936	CcSEcCtD
Darifenacin—Pain—Epirubicin—ovarian cancer	0.000619	0.000927	CcSEcCtD
Darifenacin—Constipation—Epirubicin—ovarian cancer	0.000619	0.000927	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.00061	0.000914	CcSEcCtD
Darifenacin—Insomnia—Doxorubicin—ovarian cancer	0.000606	0.000907	CcSEcCtD
Darifenacin—Dyspnoea—Doxorubicin—ovarian cancer	0.000597	0.000894	CcSEcCtD
Darifenacin—Feeling abnormal—Epirubicin—ovarian cancer	0.000597	0.000893	CcSEcCtD
Darifenacin—Somnolence—Doxorubicin—ovarian cancer	0.000596	0.000892	CcSEcCtD
Darifenacin—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000592	0.000886	CcSEcCtD
Darifenacin—Dyspepsia—Doxorubicin—ovarian cancer	0.00059	0.000883	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000578	0.000866	CcSEcCtD
Darifenacin—Pain—Doxorubicin—ovarian cancer	0.000573	0.000858	CcSEcCtD
Darifenacin—Constipation—Doxorubicin—ovarian cancer	0.000573	0.000858	CcSEcCtD
Darifenacin—Abdominal pain—Epirubicin—ovarian cancer	0.000572	0.000857	CcSEcCtD
Darifenacin—Feeling abnormal—Doxorubicin—ovarian cancer	0.000552	0.000826	CcSEcCtD
Darifenacin—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000548	0.00082	CcSEcCtD
Darifenacin—Hypersensitivity—Epirubicin—ovarian cancer	0.000533	0.000799	CcSEcCtD
Darifenacin—Abdominal pain—Doxorubicin—ovarian cancer	0.00053	0.000793	CcSEcCtD
Darifenacin—Asthenia—Epirubicin—ovarian cancer	0.000519	0.000778	CcSEcCtD
Darifenacin—Pruritus—Epirubicin—ovarian cancer	0.000512	0.000767	CcSEcCtD
Darifenacin—Diarrhoea—Epirubicin—ovarian cancer	0.000495	0.000742	CcSEcCtD
Darifenacin—Hypersensitivity—Doxorubicin—ovarian cancer	0.000494	0.000739	CcSEcCtD
Darifenacin—Asthenia—Doxorubicin—ovarian cancer	0.000481	0.00072	CcSEcCtD
Darifenacin—Dizziness—Epirubicin—ovarian cancer	0.000479	0.000717	CcSEcCtD
Darifenacin—Pruritus—Doxorubicin—ovarian cancer	0.000474	0.00071	CcSEcCtD
Darifenacin—Vomiting—Epirubicin—ovarian cancer	0.00046	0.000689	CcSEcCtD
Darifenacin—Diarrhoea—Doxorubicin—ovarian cancer	0.000458	0.000686	CcSEcCtD
Darifenacin—Rash—Epirubicin—ovarian cancer	0.000457	0.000683	CcSEcCtD
Darifenacin—Dermatitis—Epirubicin—ovarian cancer	0.000456	0.000683	CcSEcCtD
Darifenacin—Headache—Epirubicin—ovarian cancer	0.000454	0.000679	CcSEcCtD
Darifenacin—Dizziness—Doxorubicin—ovarian cancer	0.000443	0.000663	CcSEcCtD
Darifenacin—Nausea—Epirubicin—ovarian cancer	0.00043	0.000644	CcSEcCtD
Darifenacin—Vomiting—Doxorubicin—ovarian cancer	0.000426	0.000638	CcSEcCtD
Darifenacin—Rash—Doxorubicin—ovarian cancer	0.000422	0.000632	CcSEcCtD
Darifenacin—Dermatitis—Doxorubicin—ovarian cancer	0.000422	0.000632	CcSEcCtD
Darifenacin—Headache—Doxorubicin—ovarian cancer	0.00042	0.000628	CcSEcCtD
Darifenacin—Nausea—Doxorubicin—ovarian cancer	0.000398	0.000596	CcSEcCtD
Darifenacin—Fexofenadine—ABCB1—ovarian cancer	0.000386	0.284	CrCbGaD
Darifenacin—Clotrimazole—ABCB1—ovarian cancer	0.000298	0.219	CrCbGaD
Darifenacin—Fentanyl—ABCB1—ovarian cancer	0.000255	0.188	CrCbGaD
Darifenacin—Loperamide—ABCB1—ovarian cancer	0.000246	0.181	CrCbGaD
Darifenacin—Methadone—ABCB1—ovarian cancer	0.000175	0.129	CrCbGaD
